Association of obesity phenotypes with risk of cardiovascular disease mortality: a prospective cohort study
- PMID: 40665287
- PMCID: PMC12261586
- DOI: 10.1186/s12889-025-23628-w
Association of obesity phenotypes with risk of cardiovascular disease mortality: a prospective cohort study
Abstract
Background: Prospective longitudinal studies have shown inconsistent effects of obesity phenotypes on the risk of cardiovascular disease (CVD) mortality. Also, longitudinal evidence from Chinese populations remained scarce. We aimed to investigate the association of obesity phenotypes assessed by body mass index (BMI) and metabolic syndrome (MetS) with risk of CVD mortality, leveraging the unique adiposity patterns and metabolic vulnerability of Asian populations.
Methods: A subset of 26,884 participants (aged 49.30 ± 10.37 years, 39.23% men) from Taizhou longitudinal study were followed up to 8 years. Obesity phenotypes were categorized into 4 groups including metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically unhealthy non-obese (MUNO) and metabolically unhealthy obese (MUO), using BMI categories from Chinese criteria (obesity: ≥28.0 kg/m²) and MetS defined by International Diabetes Federation (IDF) consensus. The death caused by CVD were identified based on international classification of diseases-10th Revision (ICD-10). Data were analyzed using the Cox regression models and Laplace regression models.
Results: Of 26,884 participants, 15,462 (57.5%), 1,702 (6.3%), 3,656 (13.6%) and 2,064 (7.7%) subjects were classified into the MHNO, MHO, MUNO and MUO group, respectively. At the end of the follow-up, 113 (0.39%) participants died because of CVD. Compared with the MHNO group, the hazards ratios (HRs) and 95% confidence intervals (CIs) of CVD mortality were 1.73 (1.03–2.91) and 1.97 (1.11–3.52) respectively in MUNO and MUO group. The multi-adjusted 50th percentile differences (50th PDs) (95% CIs) of time at incident CVD mortality in MUNO and MUO group were 0.97 (0.00-1.93) and 1.35 (0.31–2.39) years earlier respectively than those in MHNO group. MHO group showed no significant risk elevation (HR = 1.21, 0.68–2.17) despite the earlier 50th percentile differences of CVD mortality years (50th PD = 0.94, 95%CI: 0.38–2.25).
Conclusions: Metabolic abnormalities increased the risk of CVD mortality especially in participants with obesity.
Supplementary Information: The online version contains supplementary material available at 10.1186/s12889-025-23628-w.
Keywords: CVD mortality; Metabolic syndrome; Metabolically unhealthy non-obese; Metabolically unhealthy obese; Obesity phenotypes.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the ethics committee of the Taizhou Institute of Health Sciences, Fudan University. All the participants provided written informed consent before data collection. This research conformed to the principles of the Helsinki Declaration. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
Metabolically unhealthy phenotype in normal weight population and risk of mortality and major adverse cardiac events: A meta-analysis of 41 prospective cohort studies.Diabetes Metab Syndr. 2022 Oct;16(10):102635. doi: 10.1016/j.dsx.2022.102635. Epub 2022 Sep 29. Diabetes Metab Syndr. 2022. PMID: 36240685
-
Metabolically healthy obesity and the risk of all-cause and cardiovascular disease mortality in a Korean population: a prospective cohort study.BMJ Open. 2021 Sep 6;11(9):e049063. doi: 10.1136/bmjopen-2021-049063. BMJ Open. 2021. PMID: 34489281 Free PMC article.
-
Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.Ann Intern Med. 2013 Dec 3;159(11):758-69. doi: 10.7326/0003-4819-159-11-201312030-00008. Ann Intern Med. 2013. PMID: 24297192
-
The risk of kidney dysfunction in metabolically healthy/unhealthy population with normal weight or overweight/obesity: a systematic review and meta-analysis.Eat Weight Disord. 2024 Nov 2;29(1):69. doi: 10.1007/s40519-024-01697-x. Eat Weight Disord. 2024. PMID: 39487860 Free PMC article.
-
Long-term exposure to ambient air pollutant mixture and metabolic obesity phenotypes: Results from a nationwide Korean study (2007-2019).J Expo Sci Environ Epidemiol. 2025 Jul 11. doi: 10.1038/s41370-025-00789-9. Online ahead of print. J Expo Sci Environ Epidemiol. 2025. PMID: 40646180
References
-
- WHO, Obesity. and Overweight. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9:373–92. 10.1016/S2213-8587(21)00045-0. - PubMed
-
- Tian Y, Jiang C, Wang M, Cai R, Zhang Y, He Z, et al. BMI, leisure-time physical activity, and physical fitness in adults in china: results from a series of National surveys, 2000-14. Lancet Diabetes Endocrinol. 2016;4:487–97. 10.1016/S2213-8587(16)00081-4. - PubMed
-
- Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European prospective investigation into Cancer and nutrition (EPIC)-Potsdam study. Am J Clin Nutr. 2006;84:427–33. 10.1093/ajcn/84.1.427. - PubMed
Grants and funding
- 26010105202389/Shandong Provincial Natural Science Foundation
- tsqn202306353/Taishan Young Scholar Program of Shandong Province
- 2021SFGC0503/Key R&D Program of Shandong Province
- 2021ZLGX02/Key R&D Program of Shandong Province
- 2018FY100600/National Science & Technology Fundamental Resources Investigation Project
LinkOut - more resources
Full Text Sources
Miscellaneous